Fedra Irazoque-Palazuelos

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Roy Fleischmann, Eduardo Mysler, Stephen Hall et al. · The Lancet · 2017 · 496 citations

Medicine, Pharmacology, Pharmacotherapy +12

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial

Josef S Smolen, Peter Nash, Patrick Durez et al. · The Lancet · 2013 · 354 citations · Full text

Medicine, Immunology, Pharmacotherapy +9

Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques

Philip G. Conaghan, Mikkel Østergaard, M.A. Bowes et al. · Annals of the Rheumatic Diseases · 2016 · 99 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Factors Associated with Mortality and Infections in Patients with Systemic Lupus Erythematosus with Diffuse Alveolar Hemorrhage

Marco Ulises Martínez‐Martínez, Anne K. Sturbaum, Jorge Alcocer‐Varela et al. · The Journal of Rheumatology · 2014 · 56 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +16

Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial

Won Park, Ljubinka Božić-Majstorović, Dragana Milaković et al. · mAbs · 2018 · 52 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +17